| Date Palm Tree (Phoenix dactylifera L.): Natural Products and Therapeutic Options RA Al-Alawi, JH Al-Mashiqri, JSM Al-Nadabi, BI Al-Shihi, Y Baqi Frontiers in plant science 8, 845, 2017 | 383 | 2017 |
| Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress MP Kaster, NJ Machado, HB Silva, A Nunes, AP Ardais, M Santana, ... Proceedings of the National Academy of Sciences 112 (25), 7833-7838, 2015 | 326 | 2015 |
| Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual … PA Randall, M Pardo, EJ Nunes, L López Cruz, VK Vemuri, A Makriyannis, ... Public Library of Science 7 (10), e47934, 2012 | 221 | 2012 |
| Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors CE Müller, J Iqbal, Y Baqi, H Zimmermann, A Röllich, H Stephan Bioorganic & medicinal chemistry letters 16 (23), 5943-5947, 2006 | 213 | 2006 |
| Adenosine receptor antagonists including caffeine alter fetal brain development in mice CG Silva, C Métin, W Fazeli, NJ Machado, S Darmopil, PS Launay, ... Science translational medicine 5 (197), 197ra104-197ra104, 2013 | 191 | 2013 |
| A2A adenosine receptor deletion is protective in a mouse model of Tauopathy C Laurent, S Burnouf, B Ferry, VL Batalha, JE Coelho, Y Baqi, E Malik, ... Molecular psychiatry 21 (1), 97-107, 2016 | 185 | 2016 |
| Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors M Temido-Ferreira, DG Ferreira, VL Batalha, I Marques-Morgado, ... Molecular psychiatry 25 (8), 1876-1900, 2020 | 176 | 2020 |
| Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation VL Batalha, JM Pego, BM Fontinha, AR Costenla, JS Valadas, Y Baqi, ... Molecular psychiatry 18 (3), 320-331, 2013 | 164 | 2013 |
| Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression EJ Nunes, PA Randall, EE Hart, C Freeland, SE Yohn, Y Baqi, CE Müller, ... Journal of Neuroscience 33 (49), 19120-19130, 2013 | 151 | 2013 |
| Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice M Pardo, L Lopez-Cruz, O Valverde, C Ledent, Y Baqi, CE Müller, ... Neuropharmacology 62 (5-6), 2068-2077, 2012 | 136 | 2012 |
| Development of potent and selective inhibitors of ecto-5′-nucleotidase based on an anthraquinone scaffold Y Baqi, SY Lee, J Iqbal, P Ripphausen, A Lehr, AB Scheiff, ... Journal of medicinal chemistry 53 (5), 2076-2086, 2010 | 130 | 2010 |
| High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors Y Baqi, K Atzler, M Köse, M Glänzel, CE Müller Journal of medicinal chemistry 52 (12), 3784-3793, 2009 | 118 | 2009 |
| Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/chow feeding choice task EJ Nunes, PA Randall, A Estrada, B Epling, EE Hart, CA Lee, Y Baqi, ... Psychopharmacology 231, 727-736, 2014 | 113 | 2014 |
| The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs PA Randall, CA Lee, EJ Nunes, SE Yohn, V Nowak, B Khan, P Shah, ... PloS one 9 (6), e99320, 2014 | 112 | 2014 |
| L-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies A Pinna, J Bonaventura, D Farré, M Sánchez, N Simola, J Mallol, C Lluís, ... Experimental neurology 253, 180-191, 2014 | 101 | 2014 |
| The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A 2A antagonist MSX-3 and … SE Yohn, C Thompson, PA Randall, CA Lee, CE Müller, Y Baqi, M Correa, ... Psychopharmacology 232, 1313-1323, 2015 | 100 | 2015 |
| Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents G Horváth, F Gölöncsér, C Csölle, K Király, RD Andó, M Baranyi, ... Neurobiology of disease 70, 162-178, 2014 | 98 | 2014 |
| Cardiac myocyte–secreted cAMP exerts paracrine action via adenosine receptor activation Y Sassi, A Ahles, DJJ Truong, Y Baqi, SY Lee, B Husse, JS Hulot, ... The Journal of clinical investigation 124 (12), 5385-5397, 2014 | 94 | 2014 |
| Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor Y Baqi, R Hausmann, C Rosefort, J Rettinger, G Schmalzing, CE Müller Journal of medicinal chemistry 54 (3), 817-830, 2011 | 91 | 2011 |
| Beneficial effect of a selective adenosine A2A receptor antagonist in the APPswe/PS1dE9 mouse model of Alzheimer’s Disease E Faivre, JE Coelho, K Zornbach, E Malik, Y Baqi, M Schneider, L Cellai, ... Frontiers in molecular neuroscience 11, 235, 2018 | 87 | 2018 |